Showing results (1741-1750 of 1,882) with videos related to
Sort By:
Pageof 189
Molecular Psychiatry|September 12, 2024
Safety of psychotropic medications in pregnancy: an umbrella reviewNicholas Fabiano, Stanley Wong, Arnav Gupta, et al.Haematologica|February 26, 2026
Three-year safety, efficacy, and renal outcomes of mitapivat treatment in sickle cell disease: results from the phase 2 open-label studyGeoffrey Z L Kuppens, Maria Armila D Ruiz, Myrthe J Van Dijk, et al.Journal of Medicinal Chemistry|February 18, 2017
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's DiseaseRamakrishna Nirogi, Anil Shinde, Rama Sastry Kambhampati, et al.Journal of Medicinal Chemistry|January 11, 2019
Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H3 Receptor Inverse Agonist with Robust Wake-Promoting ActivityRamakrishna Nirogi, Anil Shinde, Abdul Rasheed Mohammed, et al.Clinical Chemistry|June 13, 2021
Determining Cost-Optimal Next-Generation Sequencing Panels for Rare Disease and Pharmacogenomics TestingShanmukh Katragadda, Taryn O Hall, Radhakrishna Bettadapura, et al.Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Human impact on the diversity and virulence of the ubiquitous zoonotic parasite Toxoplasma gondiiE Keats Shwab, Pooja Saraf, Xing-Quan Zhu, et al.Current Pharmaceutical Design|January 27, 2025
Efficacy and Safety of Altibrain® as an Adjunctive Therapy for Autism Spectrum Disorder: An Open Label Trial Targeting Core SymptomsSidharth Mehan, Aakash Kumar, Prashant R Utage, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canalP A Ott, S A Piha-Paul, P Munster, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 11, 2026
A Prioritised Research Agenda to Inform the Introduction and Use of Lassa fever vaccines in West AfricaMelissa Ko, Virgil Kuassi Lokossou, Shamim Qazi, et al.The Journal of the Association of Physicians of India|July 11, 2024
Edema India: Executive Summary of Screening, Diagnosis, and Management of EdemaGirish Mathur, Gurpreet Singh Wander, Shashank R Joshi, et al.Pageof 189